A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain

NCT00631319 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

343

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Pain

Interventions

DRUG: OROS hydromorphone
DRUG: Placebo

Sponsor

Mallinckrodt